Nanolive hosted this event on “CAR T cells live and up-close: Metabolic engineering for enhanced function.” In this webinar, presented by Dr Roddy O’Connor, Research Assistant Professor at University of Pennsylvania’s renowned Center for Cellular...
With animal-testing bans in place, cosmetics R&D urgently needs reliable in vitro models that combine predictive power, reproducibility, and ethical compliance. Nanolive’s CRO services provide label-free, high-content live-cell analysis to assess ingredient safety, toxicity, and efficacy…
Phenotypic screening has re-emerged as a powerful approach for identifying and characterizing drug candidates, especially in an era where mechanism-based screening often overlooks complex biological responses…
Drug selectivity is essential for maximizing therapeutic efficacy while minimizing toxicity to healthy cells, a key driver of clinical success. Measuring drug effects on target cells alone often overlooks off-target toxicity that can deprioritize promising candidates…
Welcome to the August edition of the AI for Live Cell Insights Newsletter, bringing you to the latest live cell analyses powering drug discovery and cosmetics development. Each month, we will explore a new application of AI-based cellular analysis for label-free live...
